Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093-0607, USA.
Clin Endocrinol (Oxf). 2010 Aug;73(2):201-5. doi: 10.1111/j.1365-2265.2010.03781.x. Epub 2010 Feb 10.
Leptin is associated with blood pressure (BP) in experimental and cross-sectional studies, but only one previous prospective study of middle-aged men has reported the association between leptin and incident hypertension. We examined the association of leptin levels with incident hypertension in a population-based study of older men and women.
Longitudinal cohort study.
Participants were 602 community-dwelling older adults with normal baseline BP levels who attended a research clinic visit between 1984 and 1987 and again 4.4 years later (mean age was 66.2 +/- 11.4; 60.6% were men; mean body mass index (BMI) 24.9 +/- 3.4 kg/m(2)).
Hypertension was defined as systolic BP > or =140 mmHg and/or diastolic BP > or =90 mmHg and/or antihypertensive drug treatment. Leptin was measured by radioimmunoassay.
After an average 4.4-year follow-up (minimum 2-maximum 7 years), 106 (17.6%) new cases of hypertension were identified. At baseline, participants who developed hypertension were older and had higher systolic BP and higher total cholesterol compared to participants who remained normotensive. Baseline serum leptin levels were higher in participants who developed hypertension compared to persistent normotensives [median (25th-75th range)] [8.8(5-16) vs 7(4-11) ng/ml, P = 0.002]. In logistic regression models, leptin (log-transformed) predicted incident hypertension before and after adjustments for baseline age, BMI, systolic BP, total cholesterol, medications, and previous cardiovascular disease (OR 1.75 95% CI 1.17-2.61, P = 0.006). This association persisted after exclusion of 45 obese participants.
Higher leptin levels were independently associated with increased odds of incident hypertension in older adults.
在实验和横断面研究中,瘦素与血压(BP)有关,但只有一项先前针对中年男性的前瞻性研究报告了瘦素与高血压事件之间的关联。我们在一项针对老年男性和女性的基于人群的研究中检查了瘦素水平与高血压事件的关系。
纵向队列研究。
参加者为 602 名在基线时血压正常的社区居住的老年人,他们在 1984 年至 1987 年期间参加了研究诊所就诊,并在 4.4 年后再次就诊(平均年龄为 66.2±11.4;60.6%为男性;平均体重指数(BMI)为 24.9±3.4kg/m²)。
高血压定义为收缩压≥140mmHg 和/或舒张压≥90mmHg 和/或抗高血压药物治疗。瘦素通过放射免疫测定法测量。
平均随访 4.4 年后(最短 2 年,最长 7 年),发现 106 例(17.6%)新的高血压病例。在基线时,与持续血压正常的参与者相比,发生高血压的参与者年龄较大,收缩压和总胆固醇较高。与持续血压正常者相比,发生高血压的参与者基线时血清瘦素水平较高[中位数(25%至 75%范围)][8.8(5-16)与 7(4-11)ng/ml,P=0.002]。在逻辑回归模型中,瘦素(对数转换)预测了在调整基线年龄、BMI、收缩压、总胆固醇、药物和以前的心血管疾病后高血压的发生(OR 1.75 95%CI 1.17-2.61,P=0.006)。排除 45 名肥胖参与者后,这种关联仍然存在。
在老年人中,较高的瘦素水平与高血压事件的发生几率增加独立相关。